ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Saakshi Medtech and Panels Limited issued a revised disclosure regarding the appointment of Mr. Nandkumar Vasant Dhekne as Independent Director and Mr. Ravi Madhav Vartak as Whole-time Director.
Saakshi Medtech and Panels Limited received NSE's in-principle approval to list 2,010,259 equity shares of ₹10 each issued via preferential allotment.
Saakshi Medtech and Panels Limited has scheduled its 17th Annual General Meeting for September 30, 2026. Shareholders will consider financial statements and director appointments.
Saakshi Medtech and Panels Limited announced the re-appointment of Mr. Aniket Latkar as Chairman and Managing Director for a five-year term, effective June 8, 2026.
Saakshi Medtech and Panels Limited approved the preferential allotment of 2,010,259 equity shares at Rs. 207 per share, aggregating to Rs. 41.61 Crore.
Saakshi Medtech received in-principle approval from NSE for a preferential issue of 20,22,940 equity shares. The shares are priced at Rs. 207 each via share swap.
Saakshi Medtech received an updated valuation report for its proposed preferential issue. The report supports the fair value of assets being acquired without changing issue terms.
Saakshi Medtech responded to an NSE notice for delayed shareholding pattern filing, paying a Rs. 2,360 fine. The company has strengthened internal compliance to avoid recurrence.
Saakshi Medtech received an NSE notice imposing a Rs.2,360 fine for delayed shareholding pattern submission. The company cited portal technical issues and requested a waiver.
Saakshi Medtech and Panels Limited held an EGM on June 02, 2026. Shareholders approved increasing authorized capital and a preferential equity share issuance.
Saakshi Medtech & Panels Ltd reported revenue from operations of ₹57.2 Cr (+19.2% YoY) and net profit of ₹5.7 Cr (+338.5% YoY) for H2 FY26.
Saakshi Medtech reported a total annual income of ₹116.04 Crore for FY26. The board approved these audited standalone results showing steady financial growth for the company.
Independent Director Mr. Vishvas Vinayak Palande resigned effective May 20, 2026, citing personal reasons. His departure triggers changes in several board committees, requiring investor oversight.
Saakshi Medtech and Panels will hold a board meeting on May 26, 2026. The agenda includes reviewing standalone unaudited half-yearly financial results.
Saakshi Medtech and Panels convened an EGM for June 2, 2026. Shareholders will vote on increasing authorized capital and a preferential equity share issuance.
Saakshi Medtech approved a ₹41.87 Crore preferential equity issue and increased its authorized capital to ₹25 Crore. These moves support strategic growth and capital restructuring.
Saakshi Medtech is acquiring a 34.41% stake in Laxmi Engineering Industries for ₹41.87 Crore via share swap. This strategic investment expands its heavy engineering portfolio.
Saakshi Medtech & Panels Ltd reported net profit of ₹6.6 Cr (+88.6% YoY) for H1 FY26.